NewCardio, Inc.
NWCI · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40.8% | – | – | – |
| R&D Expenses | $4 | $3 | $2 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6 | $7 | $7 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $10 | $9 | $2 |
| Operating Income | -$9 | -$10 | -$9 | -$2 |
| % Margin | -3,674.8% | – | – | – |
| Other Income/Exp. Net | -$2 | $0 | -$5 | -$7 |
| Pre-Tax Income | -$11 | -$10 | -$14 | -$9 |
| Tax Expense | $2 | $0 | $0 | $0 |
| Net Income | -$11 | -$10 | -$14 | -$9 |
| % Margin | -4,466.2% | – | – | – |
| EPS | -0.4 | -0.44 | -0.68 | -0.85 |
| % Growth | 9.1% | 35.3% | 20% | – |
| EPS Diluted | -0.4 | -0.44 | -0.68 | -0.85 |
| Weighted Avg Shares Out | 29 | 24 | 21 | 11 |
| Weighted Avg Shares Out Dil | 29 | 24 | 21 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $7 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$9 | -$4 | -$2 |
| % Margin | -3,643.8% | – | – | – |